FMSFresenius Medical Care AG
Is it safe?
Nothing alarming, nothing pristine: comfortable debt (A) and typical volatility.
Investment-grade balance sheet. A rule of thumb on leverage, not a credit rating.
Moderate price swings, typical volatility. Worst drawdown -76% · now 20% below its 52-week high.
Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.
Can FMS take a bad year?
Fresenius Medical Care AG carries $5.24B of net debt at 1.59× EBITDA: a load its earnings can carry.
Net debt · as at Q4 2025 · under two and a half years of EBITDA, comfortable
- Net debt / EBITDA
- 1.59×
Net debt / EBITDA · 1.78× a year ago · the load is coming down
- Interest cover
- 4.75×
Interest cover · operating profit covers the interest bill, with room to spare
- Annualised volatility
- 29%
Annualised volatility · about as steady as the market itself
Details›
- Total debtQ4 2025
- $7.29B
- Cash and short-term investments
- $2.05B
- Net debt
- $5.24B
- EBITDA, trailing twelve months
- $3.29B
- Operating profit, trailing twelve months
- $1.83B
- Debt / equity
- 0.55×
- Total debt / EBITDA
- 2.21×
- Annualised volatilitytwo years of daily moves
- 29%
- Worst drawdown on file
- −76%
- Below its 52-week high
- 20%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.